Results 221 to 230 of about 445,623 (380)

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Exercise testing in pulmonary arterial hypertension and in chronic heart failure [PDF]

, 2004
Gaël Deboeck, Georges Niset, Michel Lamotte, J‐L. Vachiéry, Robert Naeije   +4 more
openalex   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Hyperuricemia as a prognostic factor in pulmonary arterial hypertension

, 2003
Danielle Bendayan, David Shitrit, Mordechai Ygla, Michael Huerta, Gershon Fink, Mordechai R. Kramer   +5 more
openalex   +1 more source

Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension [PDF]

, 2004
Noritoshi Nagaya, Shingo Kyotani, Masaaki Uematsu, Kazuyuki Ueno, Hideo Oya, Norifumi Nakanishi, Mikiyasu Shirai, Hidezo Mori, Kunio Miyatake, Kenji Kangawa   +9 more
openalex   +1 more source

Phenotyping vasodilator responsiveness in idiopathic pulmonary arterial hypertension: any role for the cardiopulmonary exercise test? [PDF]

ERJ Open Res
Sivasubramaniam G, Baccelli A, Haji G, Lo Giudice F, Weaver C, Howard L, Davies R.   +6 more
europepmc   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou, Yu Wu, Guoran Li, Yongwen Qin, Man Qi, Zhitao Jin   +5 more
wiley   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

ESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch, Ali Zafari, Shofiqul Islam, Shun Fu Lee, Rajiv Sankaranarayanan, Stephen J Greene, Mamas A Mamas, Ambarish Pandey, Harriette GC Van Spall   +8 more
wiley   +1 more source

Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan [PDF]

, 2004
D. Dunbar Ivy, Aimee Doran, Lori Claussen, Deborah Bingaman, Anji T. Yetman   +4 more
openalex   +1 more source

Peripheral venous pressure measurements to evaluate congestion in pulmonary arterial hypertension. [PDF]

Medicine (Baltimore)
Coşkun M, Yildirim A, Çetin AE, Paçaci E, Sezici E, Coşkun H, Gürsoy MO, Kurt İH, Evlice M.   +8 more
europepmc   +1 more source